CALIXAR and HÖLZEL finalize a distribution agreement
November 10, 2021
CALIXAR is proud to announce the beginning of a new distribution agreement with HÖLZEL, a German distributor.Under this agreement, HÖLZEL will promote and distribute CALIXAR’s high-quality membrane protein targets (for antibody development, drug discovery, and vaccine formulation) and customized reagents specifically designed for the extraction and/or stabilization of membrane proteins.About HÖLZELHÖLZEL was founded in 1993 by a biologist, Veit Hölzel in Cologne (Germany). This family business proposes a wide range (about 6 million) of high-quality biological products for laboratories and research. They value efficacity, reliability, flexibility and fair prices for their work and relation with customers.